“Fontan Conduit Stent-Angioplasty and Progression of Fontan-Associated Liver Disease”
Pediatric Cardiology · 2025-02 · 46 (2) · 372-378
DOI: 10.1007/s00246-024-03426-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, online erschienen am 01.03.2024. Verfasst von Umakanthan Kavin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital Colorado, Aurora, CO, 80045, USA. Hauptthemen laut MEDLINE: Fontan Procedure, Stents, Liver Diseases, Angioplasty. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of South Carolina.
Abstract (Originalsprache)
Patients with Fontan circulation insidiously develop congestive hepatopathy related to chronically reduced cardiac output and central venous hypertension, also known as Fontan-associated liver disease (FALD). Fontan pathway obstruction is increasingly detected and may accelerate FALD. The impact of conduit stent angioplasty on FALD is unknown. Retrospective, single-center review of patients with Fontan circulation who underwent conduit stent angioplasty at cardiac catheterization over 5-year period. Demographics and cardiac histories were reviewed. Labs, liver ultrasound elastography, echocardiogram, hemodynamic and angiographic data at catheterization were recorded pre- and post-stent angioplasty. Primary outcome was change in hepatic function via MELD-XI scores and liver stiffness (kPa), with secondary outcomes of ventricular function, BNP, and repeat catheterization hemodynamics. 33 patients underwent Fontan conduit stent angioplasty, 19.3 ± 7.0 years from Fontan operation. Original conduit diameter was 19.1 ± 1.9 mm. Prior to angioplasty, conduit size was reduced to a cross-sectional area 132 (91, 173) mm 2 and increased to 314 (255, 363) mm 2 post-stent. Subjects’ baseline median MELD-XI of 11 (9, 12) increased to 12 (9, 13) at 19 ± 15.5 months post-angioplasty ( n = 22, p = 0.053). There was no significant change in liver stiffness at 12.1 ± 8.9 months post-angioplasty ( n = 15, p = 0.13). Median total bilirubin significantly increased (1.4 [0.9, 1.8]), from baseline 1.1 [0.7, 1.5], p = 0.04), as did median BNP (41 [0, 148] from baseline 34 [15, 79]; p = 0.02). There were no significant changes in ventricular function or repeat invasive hemodynamics ( n = 8 subjects). Mid-term follow-up of Fontan subjects post-conduit stent angioplasty did not show improvements in non-invasive markers of FALD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Cardiology, Department of Pediatrics, Children's Hospital Colorado, Aurora, CO, 80045, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Pediatrix Cardiology Associates and Tampa Bay Adult Congenital Heart Center, Tampa, FL, 33607, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, 29425, USA.
- Division of Pediatric Cardiology, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, 29425, USA. gaydoss@musc.edu.
Förderung
- Medical University of South Carolina
Zitieren
APA
Kavin, U., Shahrier, A., Bandisode, V. M., Chowdhury, S. M., Rhodes, J. F., & Gaydos, S. S. (2025). “Fontan Conduit Stent-Angioplasty and Progression of Fontan-Associated Liver Disease”. Pediatric Cardiology, 46(2), 372-378. https://doi.org/10.1007/s00246-024-03426-8
Vancouver
Kavin U, Shahrier A, Bandisode VM, Chowdhury SM, Rhodes JF, Gaydos SS. “Fontan Conduit Stent-Angioplasty and Progression of Fontan-Associated Liver Disease”. Pediatric Cardiology. 2025;46(2):372-378. doi:10.1007/s00246-024-03426-8
BibTeX
@article{Kavin2025,
author = {Kavin, Umakanthan and Shahrier, Aniqa and Bandisode, Varsha M and Chowdhury, Shahryar M and Rhodes, John F and Gaydos, Stephanie S},
title = {“Fontan Conduit Stent-Angioplasty and Progression of Fontan-Associated Liver Disease”},
journal = {Pediatric Cardiology},
year = {2025},
volume = {46},
number = {2},
pages = {372--378},
doi = {10.1007/s00246-024-03426-8}
}
EUVIMED